SWM
CORT icon

SHP Wealth Management’s Corcept Therapeutics CORT Stock Holding History

SHP Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Sell
1,774
-202
-10% -$12.2K 0.01% 346
2026
Q1 		$79.7K Sell
1,976
-94
-5% -$3.52K 0.01% 421
2025
Q4 		$72K Buy
+2,070
New +$163K 0.01% 409

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SHP Wealth Management's CORT Position: Q2 2026 in Review

SHP Wealth Management reduced its Corcept Therapeutics (CORT) stake by 10% in Q2 2026, selling an estimated $12.2K and leaving 1,774 shares worth $154K. The position accounts for 0.01% of the portfolio, ranked #346.

SHP Wealth Management first reported a position in CORT in Q4 2025 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • SHP Wealth Management held 1,774 shares of Corcept Therapeutics worth $154K as of Q2 2026.
  • SHP Wealth Management sold 202 Corcept Therapeutics shares in Q2 2026, an estimated $12.2K.
  • Corcept Therapeutics made up 0.01% of SHP Wealth Management's portfolio in Q2 2026, its #346 holding.
  • SHP Wealth Management first reported a position in Corcept Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.